Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T16:21:11.961Z.
Calculation as of: 2026-10-06T16:21:11.961Z.
Quote observation: 2026-10-06T16:20:43.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 098b8cc383d7c70bc2f58c50adf850e5cd93194028a42938ba247026a8eec5c0
EARNINGS YIELD
N/A
Market Cap
$1.62B
Earnings Yield
6.48%
TTM Avg
4.06%
3Y Avg
2.87%
5Y Avg
2.87%
Market Cap
$1.61B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | $1.65B | N/A | N/A | N/A | N/A |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.63B | N/A | N/A | N/A | N/A |
| Septerna Inc (SEPN)vs › | $1.67B | N/A | 6.67% | 6.67% | 6.67% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.62B | 6.48% | 4.06% | 2.87% | 2.87% |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.61B | N/A | N/A | N/A | N/A |
| Omnicell, Inc. (OMCL)vs › | $1.60B | 2.41% | 1.15% | 1.23% | 1.24% |
| Personalis, Inc. (PSNL)vs › | $1.70B | N/A | N/A | N/A | N/A |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.70B | N/A | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.72B | N/A | 4.44% | 2.95% | 2.72% |
| uniQure N.V. (QURE)vs › | $1.55B | N/A | 32.82% | 32.44% | 32.44% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
